| Metric | FY 2024↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.5B | $0.5B | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.5B | $-0.0B | $-0.1B | $-0.0B | — | — | — | — |
| EPS (Basic) | $-10.23 | $-0.31 | $-2.40 | $-0.45 | — | — | — | — |
| EPS (Diluted) | $-10.23 | $-0.31 | $-2.40 | $-0.45 | — | — | — | — |
| Metric | FY 2024↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1B | $13.2B | $13.3B | $14.6B | — | — | $28.9B | $28.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.1B | — | — | — | — |
| Total Liabilities | $6.9B | $12.1B | $11.8B | $13.0B | — | — | $28.4B | $28.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $1.1B | $1.5B | $1.6B | — | — | — | — |
| Metric | FY 2024↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | $-0.2B | $-0.3B | $-1.5B | — | — | — | — |
| Investing Cash Flow | — | $0.4B | $1.0B | $1.6B | — | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | $-0.3B | $-0.7B | $-0.6B | — | — | — | — |